Clinical Trials Browser

OTHER × Lymphoma, Extranodal NK-T-Cell × camrelizumab × Clear all

NCT03701022 2018-10-09

PD1 Combined With Apatinib in Patients With Relapsed or Refractory NK/T Cell Lymphoma

Phase 2 Unknown

Lymphoma, Extranodal NK-T-Cell